Fingerprint
Dive into the research topics of 'Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma
Stephen M. Ansell, Anne J. Novak, Steven Ziesmer, Tammy Price-Troska, Betsy Laplant, Stacey R. Dillon, Thomas E. Witzig
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations